DEERFIELD MANAGEMENT COMPANY, L.P. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001009258

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2025 · 147 positions · Total reported value $6.22B · Top-10 concentration 54.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 38.6% · 10 new · 12 cut · 12 exited

Active Share (vs S&P 500): 99.6% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +17.1% · vs SPY +2.2% · Prev Value $7.59B — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2025 13F filing, DEERFIELD MANAGEMENT COMPANY, L.P. disclosed 147 equity positions with a combined reported value of $6.22B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 54.5% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were NUVL ($1.56B), CNC ($322.76M), MRUS ($286.87M). By sector, the heaviest allocations are Health Care 63.9%, Technology 1.4%. Versus the prior quarter, allocation shifted away from Other (-0.5pp).

Versus the prior quarter, DEERFIELD MANAGEMENT COMPANY, L.P. opened 10 new positions, trimmed 12 and fully exited 12, a turnover rate of 38.6% of positions. The portfolio's overlap with the prior quarter was 61% of names.

The largest new positions opened in Q3 2025 were BMY ($105.43M), IONS ($82.66M), BBOT ($56.57M).

Of the 12 positions fully exited versus the prior quarter, the largest were OSCR ($249.77M), LQDA ($20.15M), MREO ($18.19M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • BMY BRISTOL-MYERS SQUIBB CO · $105.43M
  • IONS IONIS PHARMACEUTICALS INC · $82.66M
  • BBOT BridgeBio Oncology Therapeutic Inc · $56.57M
  • CRMD CORMEDIX INC · $38.66M
  • CELC CELCUITY INC · $36.24M
  • ARWR ARROWHEAD PHARMACEUTICALS IN · $34.25M
  • CDNA CAREDX INC · $31.86M
  • ACHC ACADIA HEALTHCARE COMPANY INC COM · $29.44M

Fully Exited (vs previous quarter)

  • OSCR OSCAR HEALTH INC · prev qtr: $249.77M
  • LQDA LIQUIDIA CORPORATION · prev qtr: $20.15M
  • MREO MEREO BIOPHARMA GROUP FUNSPONSORED ADR 1 ADR REPS 5 ORD SHS · prev qtr: $18.19M
  • NVCR NOVOCURE LTD · prev qtr: $14.69M
  • RXST RXSIGHT INC · prev qtr: $11.56M
  • DCTH DELCATH SYS INC · prev qtr: $11.05M
  • PCVX VAXCYTE INC · prev qtr: $7.31M
  • SLP SIMULATIONS PLUS INC · prev qtr: $6.18M

Insider Transactions (Form 4)

Latest DEERFIELD MANAGEMENT COMPANY, L.P. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-07-15 D Nuvalent, Inc. 3,444 $124.00 SEC filing
2026-07-15 U Nuvalent, Inc. 5,146 $124.00 SEC filing
2026-07-15 D Nuvalent, Inc. 650,000 $124.00 SEC filing
2026-07-15 D Nuvalent, Inc. 8,299,225 $124.00 SEC filing
2026-06-16 Award Nuvalent, Inc. 3,444 — SEC filing
2026-06-11 Conversion Parabilis Medicines, Inc. 407,132 — SEC filing
2026-06-11 Conversion Parabilis Medicines, Inc. 260,992 — SEC filing
2026-06-11 Conversion Parabilis Medicines, Inc. 149,238 — SEC filing

All insider transactions →

Fund Profile

Deerfield Management Company, L.P. is a New York-based hedge fund founded by Marianne and James Chadwin, known for its quantitative and fundamental research approach focused primarily on healthcare and biotechnology investments.

Investment Approach

Combines quantitative analysis with fundamental research

Specializes in healthcare and biotechnology sectors

Utilizes both public and private investment strategies

Asset Classes & Strategy

Primarily focused on long/short equity positions

Specializes in healthcare and biotechnology investments

Also invests in other sectors with strong fundamental research

Key Personnel

Marianne Chadwin (Co-founder)

James Chadwin (Co-founder)

Team of experienced portfolio managers and researchers

AUM & Performance

Manages approximately $19.1 billion in assets under management

Performance data not publicly disclosed

All information is based on publicly available SEC filings and company disclosures.

Sector Allocation

Health Care 63.9%
Technology 1.4%
Financials 0.0%
Materials 0.0%
Other 32.6%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 17.99M $1.56B 25.02%
25.02%
Hold
2 9.05M $322.76M 5.19%
5.19%
Add
3 3.05M $286.87M 4.61%
4.61%
Reduce
4 24.10M $238.58M 3.84%
3.84%
Hold
5 425.99K $178.58M 2.87%
2.87%
Reduce
6 3.65M $170.47M 2.74%
2.74%
Add
7 6.99M $168.45M 2.71%
2.71%
Reduce
8 70.00M $168.19M 2.71%
2.71%
Hold
9 1.18M $166.26M 2.67%
2.67%
Add
10 9.05M $130.00M 2.09%
2.09%
Add
11 4.27M $121.34M 1.95%
1.95%
Reduce
12 3.64M $105.81M 1.70%
1.70%
Add
13 2.34M $105.43M 1.70%
1.70%
New
14 11.48M $102.73M 1.65%
1.65%
Add
15 30.61M $98.86M 1.59%
1.59%
Add
16 11.64M $98.60M 1.59%
1.59%
Reduce
17 4.97M $98.00M 1.58%
1.58%
Add
18 2.96M $96.60M 1.55%
1.55%
Hold
19 12.17M $92.36M 1.49%
1.49%
Add
20 1.03M $86.45M 1.39%
1.39%
Add
21 3.30M $84.18M 1.35%
1.35%
Reduce
22 60.00M $82.66M 1.33%
1.33%
New
23 6.74M $82.36M 1.32%
1.32%
Add
24 1.05M $77.74M 1.25%
1.25%
Add
25 7.50M $75.41M 1.21%
1.21%
Reduce
26 471.00K $67.83M 1.09%
1.09%
Reduce
27 226.07K $63.39M 1.02%
1.02%
Hold
28 2.44M $60.94M 0.98%
0.98%
Add
29 919.40K $60.75M 0.98%
0.98%
Hold
30 2.15M $58.58M 0.94%
0.94%
Reduce
31 4.89M $56.57M 0.91%
0.91%
New
32 2.29M $46.73M 0.75%
0.75%
Add
33 840.85K $44.57M 0.72%
0.72%
Add
34 3.32M $38.66M 0.62%
0.62%
New
35 4.75M $38.03M 0.61%
0.61%
Reduce
36 2.62M $36.97M 0.59%
0.59%
Reduce
37 34.28M $36.86M 0.59%
0.59%
Add
38 733.53K $36.24M 0.58%
0.58%
New
39 760.20K $35.75M 0.57%
0.57%
Add
40 1.56M $34.70M 0.56%
0.56%
Hold
41 4.45M $34.33M 0.55%
0.55%
Add
42 993.00K $34.25M 0.55%
0.55%
New
43 4.71M $33.17M 0.53%
0.53%
Add
44 572.26K $32.39M 0.52%
0.52%
Reduce
45 2.19M $31.86M 0.51%
0.51%
New
46 67.94K $30.98M 0.50%
0.50%
Reduce
47 1.19M $29.44M 0.47%
0.47%
New
48 970.59K $28.55M 0.46%
0.46%
Hold
49 7.96M $28.43M 0.46%
0.46%
Hold
50 1.12M $26.27M 0.42%
0.42%
Add

FAQ

What did DEERFIELD MANAGEMENT COMPANY, L.P. buy in 2025-Q3?

In its 2025-Q3 13F filing, DEERFIELD MANAGEMENT COMPANY, L.P. reported 147 equity positions worth $6.22B in aggregate; its largest disclosed positions were NUVL ($1.56B), CNC ($322.76M), MRUS ($286.87M).

How large is DEERFIELD MANAGEMENT COMPANY, L.P.'s portfolio?

DEERFIELD MANAGEMENT COMPANY, L.P. reported $6.22B of long equity holdings across 147 positions as of 2025-Q3. Top-10 holdings account for 54.5% of reported value.

What is DEERFIELD MANAGEMENT COMPANY, L.P.'s investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/deerfield-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →